[Lys(Ac)8]-Histone H4 (1-20) – 1 mg

Overview

The [Lys(Ac)8]-Histone H4 (1-20) peptide is a specially engineered histone modification peptide that plays an essential role in cancer research, particularly in relation to non-small-cell lung cancer (NSCLC). Acetylation at lysine 8 is not merely a post-translational modification; it serves as a biomarker that could predict patient prognosis following surgical resection. Recent studies suggest that this specific histone modification might facilitate the recruitment of DNA polymerases involved in somatic hypermutation, a crucial process in cancer evolution and progression. By purchasing this peptide, you equip your research with a vital tool for understanding cancer biology and therapeutic responses.

Key Features

• Acetylated at lysine 8 for enhanced functional relevance
• Designed for studies focused on cancer prognosis and mutations
• Produced under stringent quality control to ensure high purity
• Available in 1 mg quantities to meet your experimental needs
• Compatible with various labeling and detection methodologies

Specifications

FAQ

What is the significance of lysine 8 acetylation in cancer research?

Lysine 8 acetylation on histone H4 is associated with key regulatory mechanisms in gene expression and has implications in cancer prognosis, making it crucial for studies into NSCLC.

How can [Lys(Ac)8]-Histone H4 (1-20) be used in my research?

This peptide can be utilized in various assays to explore histone modifications and their biological impacts, particularly in relation to DNA repair and mutation rates in cancer cells.

Where can I find additional peptide options?

You can explore our extensive range of peptides on our website, including highly specialized products like PKG Substrate [RKRSRAE] and Autocamtide-2 [KKALRRQETVDAL].

Order the [Lys(Ac)8]-Histone H4 (1-20) today and advance your research into the intricacies of cancer biology!

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.